ABT

Abbott Laboratories

119.01 USD
+1.14 (+0.97%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Abbott Laboratories stock is up 4.39% since 30 days ago. The dividend yield is 1.94% and its next earnings date is Apr 17, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 52% of the previous 49 February’s closed higher than January. In the last 10 Unusual Options Trades, there were 10 CALLs. 100% of analysts rate it a buy.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
20 Feb 20:03 21 Jun, 2024 105.00 CALL 20 498
21 Feb 14:30 17 Jan, 2025 110.00 CALL 25 827
21 Feb 17:14 17 May, 2024 120.00 CALL 202 3478
21 Feb 18:10 23 Feb, 2024 118.00 CALL 450 232
21 Feb 20:32 15 Mar, 2024 115.00 CALL 100 5053
21 Feb 20:49 16 Jan, 2026 110.00 CALL 145 57
22 Feb 15:04 19 Apr, 2024 120.00 CALL 109 13052
22 Feb 15:21 19 Apr, 2024 120.00 CALL 220 13052
22 Feb 15:23 19 Apr, 2024 120.00 CALL 225 13052
22 Feb 15:25 21 Jun, 2024 120.00 CALL 59 2323

About Abbott Laboratories

Abbott Laboratories discovers, develops, manufactures, and sells health care products. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases.

  • RBC Capital
    Wed Feb 14, 09:48
    buy
    confirm
  • Barclays
    Fri Jan 26, 13:20
    buy
    confirm
  • Citigroup
    Thu Jan 25, 11:26
    buy
    confirm
  • RBC Capital
    Thu Jan 25, 10:55
    buy
    confirm
  • Raymond James
    Thu Jan 25, 07:24
    buy
    confirm